Inactive Instrument

BIOGAIA B Share Price Xetra

Equities

BGL

SE0000470395

Pharmaceuticals

End-of-day quote Xetra
- EUR - Intraday chart for BIOGAIA B

Financials

Sales 2024 * 1.44B 138M 127M 10.74B Sales 2025 * 1.6B 153M 141M 11.92B Capitalization 12.57B 1.2B 1.11B 93.68B
Net income 2024 * 413M 39.44M 36.38M 3.08B Net income 2025 * 446M 42.59M 39.28M 3.32B EV / Sales 2024 * 7.85 x
Net cash position 2024 * 1.26B 121M 111M 9.4B Net cash position 2025 * 976M 93.23M 85.98M 7.27B EV / Sales 2025 * 7.25 x
P/E ratio 2024 *
30.4 x
P/E ratio 2025 *
28.2 x
Employees -
Yield 2024 *
5.54%
Yield 2025 *
5.54%
Free-Float 80.06%
More Fundamentals * Assessed data
Managers TitleAgeSince
Founder 74 31/12/89
Chief Executive Officer 58 31/08/23
Director of Finance/CFO 57 04/11/19
Members of the board TitleAgeSince
Director/Board Member 75 31/12/02
Founder 74 31/12/89
Director/Board Member 68 04/05/23
More insiders
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Calendar
More about the company